Clinical Trials

Phase 2 Active not recruiting

Neoplasms, Colorectal Neoplasms

NCT04485949 2026-02-10

A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma

93 enrolled

CNS

Glioblastoma

NCT04567420 2025-10-16

DARE

Phase 2 Recruiting

70 enrolled

Breast

Breast Neoplasms

NCT06636682 2024-10-21

FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer

Phase 2 Recruiting

100 enrolled

Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT04099888 2023-09-11

RELEASE

41 enrolled 17 charts

Bile Duct Neoplasms, Cholangiocarcinoma

NCT04733833 2023-02-01

A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19

5 enrolled

Lymphoid

COVID-19, Lymphoma, Follicular

NCT02107937 2022-05-04

Phase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian Carcinoma

136 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT03329690 2022-03-18

DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Gastric Cancer [DESTINY-Gastric01]

233 enrolled 26 charts 1 FDA

Adenocarcinoma, Gastrointestinal Neoplasms

NCT02448810 2021-05-25

Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer

115 enrolled 22 charts

Colorectal Neoplasms

NCT03301597 2021-03-30

LAUNCH

Other hematologic neoplasm

146 enrolled

Bacterial Infections, Mycoses, Leukemia, Myeloid, Acute

NCT01883362 2021-03-17

RADIUS

Other hematologic neoplasm

60 enrolled 17 charts

Leukemia, Myeloid, Acute

NCT03472053 2020-05-19

A Study of BIO-11006 in the Treatment of Advanced Non-Small Cell Lung Cancer

60 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT02200081 2018-11-15

IMPULSE

103 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT02107950 2018-08-15

Phase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian Carcinoma

71 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT01353222 2017-05-25

DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma

142 enrolled 13 charts

Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasms, Neoplasms by Site, Ureteral Neoplasms, Urethral Neoplasms

NCT02107378 2016-11-30

Efficacy of DCVAC/OvCa Plus Standard of Care in Relapsed Platinum Resistant Epithelial Ovarian Carcinoma

22 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Recurrence

NCT00977379 2016-11-15

XERAD